by Michael Nevradakis, Ph.D. at the Defender
The FDA will also immediately add warnings to Tylenol and other products that contain acetaminophen, warning pregnant women of a possible link between acetaminophen and autism, and will also advise physicians about the risks. The agency is also set to approve leucovorin, a medication commonly used to treat cancer, as an autism treatment.
U.S. public health agencies are collaborating on extensive studies that will examine all the possible causes of autism, including vaccines, U.S. Health Secretary Robert F. Kennedy Jr., President Donald Trump and several public health officials announced today during a White House event.
According to today’s announcement, the U.S. Food and Drug Administration (FDA) will also immediately add warnings to Tylenol and other products that contain acetaminophen, warning pregnant women of a possible link between acetaminophen and autism, and will also advise physicians and the public about the risks.
The FDA is also set to approve leucovorin, a medication commonly used in cancer treatments to counter the harmful side effects of other drugs, as a treatment for symptoms associated with autism, based on promising results in clinical studies among children with folate deficiency.
During today’s announcement, Kennedy emphasized the potential role of vaccines in causing autism. He said:
“One area that we are closely examining … is vaccines. Some 70% of mothers who have children with autism believe that their child was injured by a vaccine. President Trump believes that we should be listening to these mothers instead of gaslighting and marginalizing them like prior administrations.
“It will take time for an honest look at this topic by scientists, but I want to reassure the people in the autism community that we will be uncompromising and relentless in our search for answers. We will perform the studies that should have been performed 25 years ago. Whatever the answer is, we will tell you what we find.”
Noting that he’s “been waiting for this meeting for 20 years,…
Continue Reading